Spyre Therapeutics (SYRE) Q4 2016 Earnings

8MarExpected
Q1 2016
Q2 2016
Q3 2016
Q4 2016
-177.42
-118.43
-59.43
-0.43

Details

Expected EPS
-0.46
Actual EPS
-0.56
Surprise EPS
-0.1
Surprise Percent
+21.74%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.56 per share for Q4 2016.

0 Comments

Share your thoughts